Mayo Clinic is internationally known for active research programs in hypertrophic cardiomyopathy, including genetic research, diagnostic methods and treatment options. Mayo Clinic physicians strive to continually bring research findings to the clinical treatment of patients. Current research involves the evaluation of surgical and non-surgical procedures and the use of newer diagnostic technologies. See more information about cardiovascular research efforts on the research Web site.
Hypertrophic Cardiomyopathy in the Windland Smith Rice Sudden Death Genomics Laboratory — Genotype/Phenotype Relationships in Hypertrophic Cardiomyopathy.
See a list of publications by Mayo Clinic doctors on hypertrophic cardiomyopathy on PubMed, a service of the National Library of Medicine.